Electrical Stimulation Devices Market Scope And Analysis

  • Report Code : TIPRE00003313
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Electrical Stimulation Devices Market Scope and Analysis by 2031

Buy Now


Electrical Stimulation Devices Market Report Scope

Report Attribute Details
Market size in 2021 US$ 6.69 Billion
Market Size by 2031 US$ 16.27 Billion
Global CAGR (2023 - 2031) 9.3%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Device Type
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Vagus Nerve Stimulation
By Application
  • Pain Management
  • Neurological and Movement Disorder Management
  • Musculoskeletal Disorder Management
  • Metabolism and GIT Management
  • Incontinence Management
  • Other Application
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Boston Scientific Corporation
  • Medtronic
  • Abbott
  • BTL
  • DJO Global Inc
  • Ava Science Inc
  • NEVRO CORP
  • Zynex MedicalLaborie Inc
  • LivaNova PLC
  • NeuroMetri
  • Electrical Stimulation Devices Market News and Recent Developments

    The electrical stimulation devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for electrical stimulation devices and strategies:

    • Boston Scientific Corporation announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication of the WaveWriter SCS Systems for the treatment of chronic low back and leg pain in people without prior back surgery, commonly referred to as non-surgical back pain (NSBP). (Source: Boston Scientific Corporation, Press Release, 2024)
    • Boston Scientific Corporation announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication of the WaveWriter Alpha Spinal Cord Stimulator (SCS) Systems for the treatment of painful diabetic peripheral neuropathy (DPN), a complication of diabetes that can affect the lower extremities of the body. Source: (Boston Scientific Corporation, Press Release, 2023)

    Electrical Stimulation Devices Market Report Coverage and Deliverables

    The “Electrical Stimulation Devices Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles